David Lloyd Emerson
13Patents
2h-index
12Co-inventors
51Inventor score
Filing activity: Feb 24, 2000 → Dec 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6740335B1 | Liposomal camptothecin formulations | Human Necessities | 10 | Expired |
| US8273789B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 2 | Active |
| US6689381B2 | Liposomal benzoquinazoline thymidylate synthase inhibitor formulations | Human Necessities | 1 | Expired |
| US11147793B2 | Taxane analogs for the treatment of brain cancer | Chemistry; Metallurgy | 0 | Active |
| US10143677B2 | Taxane analogs for the treatment of brain cancer | Chemistry; Metallurgy | 0 | Active |
| US10450323B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 0 | Active |
| US9616043B2 | Taxane analogs for the treatment of brain cancer | Chemistry; Metallurgy | 0 | Active |
| US11873308B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 0 | Active |
| US10745408B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 0 | Active |
| US9132118B2 | Taxane analogs for the treatment of brain cancer | Chemistry; Metallurgy | 0 | Active |
| US9802951B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 0 | Active |
| US11220512B2 | Biologically active taxane analogs and methods of treatment by oral administration | Human Necessities | 0 | Active |
| US11786504B2 | Taxane analogs for the treatment of brain cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.